PGx found to be “one of the most clinically actionable advances that has come out of human genetics.”

Stanford Medicine professor Russ Altman, MD, PhD, and a team of scientists found that almost everyone (99.5% of individuals) is likely to have an abnormal or “atypical” response to at least one therapeutic drug. Read the whole article here:

Implementation, Industry News, Inspiration, Research + Publications